-
TiO2-Nanoparticle Sonodynamic Therapy Prevents PCO via Ferro
2026-04-29
This study demonstrates that titanium dioxide nanoparticle–enhanced sonodynamic therapy (SDT) can effectively prevent posterior capsular opacification (PCO) by inducing ferroptosis in residual lens epithelial cells. The research identifies precise ultrasound and nanoparticle parameters for targeted cell death, implicating GPX4 downregulation and ROS-driven lipid peroxidation as key mechanisms.
-
Quercetin Protects Cataract Lenses via Hippo Pathway Modulat
2026-04-28
This study reveals that quercetin mitigates lens opacification and promotes epithelial cell survival in cataract models by inactivating the Hippo signaling pathway. The findings highlight a mechanistic link between natural compounds and Hippo pathway modulation, providing a foundation for non-surgical cataract interventions.
-
Redefining Antioxidant Assays: L-Glutathione Reduced in Canc
2026-04-28
Explore how L-Glutathione Reduced advances cancer metabolism research by integrating redox biology, assay sensitivity, and mechanistic insight. This article uniquely connects reduced glutathione’s biochemical role to emerging strategies in antioxidant and metabolic pathway analysis.
-
Baicalin Restores Visual Cortex Plasticity in Adult Amblyopi
2026-04-27
This study demonstrates that Baicalin, a flavone glycoside from Scutellaria baicalensis, reactivates ocular dominance plasticity in adult mice with amblyopia. The findings reveal a mechanistically specific, pharmacological strategy for reversing visual impairment beyond the critical developmental period, offering new translational potential in neuroplasticity research.
-
Acridine Orange hydrochloride: Technical Guidance for Nuclei
2026-04-27
Acridine Orange hydrochloride (SKU B7747) provides researchers with a robust, dual-fluorescence dye for differential staining of DNA and RNA. Its membrane permeability and spectral properties enable applications such as cell cycle analysis and apoptosis detection, but efficacy depends on correct solution preparation and prompt usage. This product is not recommended for long-term solution storage or applications outside nucleic acid staining workflows.
-
ω-Agatoxin IVA TFA: Precision in Cav2.1 Channel Blockade for
2026-04-26
This thought-leadership article explores the mechanistic underpinnings and strategic applications of ω-Agatoxin IVA TFA, a high-affinity P/Q-type calcium channel blocker. We contextualize its role in neuronal calcium current recording, synaptic transmission research, and epilepsy animal models, critically evaluating both its neuroprotective promise and its limitations as revealed by foundational studies. By bridging molecular specificity with translational strategy, we guide researchers on leveraging this tool to advance discoveries in neuropharmacology and disease modeling.
-
Exemestane: Protocol Optimization in Breast Cancer Research
2026-04-25
Exemestane, an irreversible steroidal aromatase inhibitor from APExBIO, empowers robust modeling of estrogen biosynthesis inhibition for advanced breast cancer research. This guide delivers actionable protocol enhancements, troubleshooting solutions, and comparative insights to maximize reproducibility and translational relevance.
-
Pharmacokinetic Variability of CSBTA in MASLD/MASH Mouse Mod
2026-04-24
This study delineates how metabolic disease status alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mouse models of MASLD/MASH. Using advanced UHPLC-MS/MS techniques and cellular assays, the research identifies key enzymatic and transporter-mediated sources of variability, providing a framework for optimizing dosing strategies in preclinical and translational settings.
-
Butylhydroxyanisole (BHA): Precision Antioxidant Use in ROS
2026-04-24
Explore the advanced application of butylated hydroxyanisole (BHA) as a synthetic antioxidant for oxidative stress research. This article offers an in-depth, assay-level guide for optimal ROS modulation and apoptosis pathway studies, highlighting what sets BHA apart in experimental design.
-
Berberrubine Chloride Inhibits Thrombosis via the Vitamin K
2026-04-23
This study integrates metabolomics and molecular docking to show that berberrubine chloride, a natural isoquinoline alkaloid, inhibits thrombosis in mice by regulating the vitamin K catalytic cycle. The findings offer mechanistic insight into its antithrombotic effect and provide a foundation for developing safer anticoagulant agents.
-
SR-202 (PPAR Antagonist): Precision Control in Macrophage Po
2026-04-23
Explore how SR-202, a selective PPARγ antagonist, enables precision control of macrophage polarization and adipogenesis in advanced immunometabolic research. This article uniquely examines the impact of SR-202 on experimental assay design and translational study rigor.
-
Cy7 NHS Ester: Protocols and QC for Near-Infrared Protein La
2026-04-22
Cy7 NHS ester is a sulfonated, water-soluble near-infrared dye optimized for covalent labeling of proteins and peptides via amino groups, without the use of organic co-solvents. It is best suited for in vitro and in vivo imaging where maintaining protein integrity and minimizing fluorescence quenching are critical. This reagent should not be used for targets lacking primary amines or when long-term storage of dye solutions is required.
-
Thiazovivin: Protocols for ROCK Inhibition in Stem Cell Rese
2026-04-22
Thiazovivin is a ROCK inhibitor that addresses the challenges of low efficiency in fibroblast reprogramming and poor survival of human embryonic stem cells post-dissociation. It is suitable for workflows requiring enhanced induced pluripotent stem cell generation and cell viability, but should not be used for diagnostic or medical applications.
-
UTP Solution (100 mM): Reliable RNA and Metabolic Assay Reag
2026-04-21
This article delivers practical insights for researchers seeking reproducible results in RNA transcription and metabolic assays. Grounded in real-world lab scenarios, it explores how 'UTP Solution (100 mM)' (SKU K1048) from APExBIO addresses workflow bottlenecks with validated purity and compatibility. Readers gain actionable, evidence-based strategies for optimizing nucleotide-dependent assays.
-
SGI-1027: Precision DNA Methyltransferase Inhibition in Canc
2026-04-21
SGI-1027 is redefining cancer epigenetics with its dual-action mechanism—potent, selective DNA methylation inhibition and DNMT1 degradation—enabling reactivation of silenced tumor suppressor genes. This guide delivers practical, evidence-driven workflows, troubleshooting strategies, and highlights from current in vitro research to help scientists unlock the full potential of this APExBIO DNA methyltransferase inhibitor.
451 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page